Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Body

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2008
Practical guidance for the management of aromatase inhibitor-associated bone lossP Hadji, J-J Body, M S Aapro, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Phase I clinical trial with carbetimerP Dodion, D de Valeriola, J J Body, et al.
Journal of Osteoporosis|January 7, 2011
Loading and skeletal development and maintenanceP Bergmann, J J Body, S Boonen, et al.
Maturitas|August 1, 1996
Cyclical pamidronate infusions in postmenopausal osteoporosisA Peretz, J J Body, J C Dumon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1991
Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancerV Grill, P Ho, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 18, 2010
Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patientsV Huyge, C Garcia, J Alexiou, et al.
Calcified Tissue International|June 23, 2021
MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® ScoreA Mugisha, P Bergmann, V Kinnard, et al.
Clinical Chemistry|May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancerJ J Body, M Paesmans, J P Sculier, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2008
Practical guidance for the management of aromatase inhibitor-associated bone lossP Hadji, J-J Body, M S Aapro, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Phase I clinical trial with carbetimerP Dodion, D de Valeriola, J J Body, et al.
Journal of Osteoporosis|January 7, 2011
Loading and skeletal development and maintenanceP Bergmann, J J Body, S Boonen, et al.
Maturitas|August 1, 1996
Cyclical pamidronate infusions in postmenopausal osteoporosisA Peretz, J J Body, J C Dumon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2004
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1991
Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancerV Grill, P Ho, J J Body, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 18, 2010
Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patientsV Huyge, C Garcia, J Alexiou, et al.
Calcified Tissue International|June 23, 2021
MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® ScoreA Mugisha, P Bergmann, V Kinnard, et al.
Clinical Chemistry|May 1, 1992
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancerJ J Body, M Paesmans, J P Sculier, et al.
Pageof 22